• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射免疫球蛋白治疗后中性粒细胞减少与川崎病患儿冠状动脉病变的相关性:一项病例对照研究

Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.

作者信息

Wang Zhenquan, Weng Fengfeng, Li Chen, Shi Hongying, Tang Zhangke, Qiu Huixian, He Yue'e, Wu Rongzhou, Chu Maoping

机构信息

Children's Heart Center, the Second Affiliated Hospital and Yuying Children's Hospital, Institute of cardiovascular development and translational medicine, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.

Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310051, China.

出版信息

BMC Pediatr. 2018 Feb 21;18(1):76. doi: 10.1186/s12887-018-1032-z.

DOI:10.1186/s12887-018-1032-z
PMID:29466965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5822559/
Abstract

BACKGROUND

To evaluate differences in laboratory parameters, clinical presentation, and incidence of coronary artery lesions (CAL) between children with neutropenic and non-neutropenic Kawasaki disease (KD).

METHODS

All consecutive KD patients that presented to the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University in Wenzhou, China between January 2005 and December 2015 were included in this study. Patients were divided into two groups (KD with neutropenia (NKD) and KD without neutropenia (NNKD)) based on whether or not they developed neutropenia during the course of treatment. We compared differences in clinical manifestations, laboratory parameters, and treatment protocols between groups. We also evaluated the relationship between neutropenia with immunoglobulin dosage and incidence of CAL.

RESULTS

An IVIG treatment regimen of 2 g/kg1d was associated with a lower incidence of neutropenia compared to the 1 g/kg2d protocol. The incidence of CAL was higher in KD patients with neutropenia than in those without. Subgroup analysis showed no difference in the incidence of CAL among the different age groups between KD patients with and without neutropenia.

CONCLUSIONS

Follow up ultrasonic echocardiography should be performed in KD patients with neutropenia in order to allow for early detection of CAL and timely intervention.

摘要

背景

评估中性粒细胞减少性与非中性粒细胞减少性川崎病(KD)患儿在实验室参数、临床表现及冠状动脉病变(CAL)发生率方面的差异。

方法

纳入2005年1月至2015年12月期间在中国温州医科大学附属第二医院育英儿童医院就诊的所有连续性KD患者。根据治疗过程中是否出现中性粒细胞减少,将患者分为两组(中性粒细胞减少性KD(NKD)和非中性粒细胞减少性KD(NNKD))。我们比较了两组之间的临床表现、实验室参数及治疗方案的差异。我们还评估了中性粒细胞减少与免疫球蛋白剂量及CAL发生率之间的关系。

结果

与1g/kg2d方案相比,2g/kg1d的静脉注射免疫球蛋白(IVIG)治疗方案与较低的中性粒细胞减少发生率相关。中性粒细胞减少的KD患者中CAL的发生率高于无中性粒细胞减少的患者。亚组分析显示,中性粒细胞减少和非中性粒细胞减少的KD患者不同年龄组之间CAL的发生率无差异。

结论

对中性粒细胞减少的KD患者应进行超声心动图随访,以便早期发现CAL并及时干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deae/5822559/e79596071620/12887_2018_1032_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deae/5822559/e79596071620/12887_2018_1032_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deae/5822559/e79596071620/12887_2018_1032_Fig1_HTML.jpg

相似文献

1
Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.静脉注射免疫球蛋白治疗后中性粒细胞减少与川崎病患儿冠状动脉病变的相关性:一项病例对照研究
BMC Pediatr. 2018 Feb 21;18(1):76. doi: 10.1186/s12887-018-1032-z.
2
Association between maternal age and outcomes in Kawasaki disease patients.母亲年龄与川崎病患者结局的关系。
Pediatr Rheumatol Online J. 2019 Jul 19;17(1):46. doi: 10.1186/s12969-019-0348-z.
3
A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.一项关于川崎病静脉注射免疫球蛋白无反应的多中心研究。
Pediatr Cardiol. 2015 Aug;36(6):1166-72. doi: 10.1007/s00246-015-1138-0. Epub 2015 Mar 27.
4
[Clinical analysis of 942 cases of Kawasaki disease].942例川崎病临床分析
Zhonghua Er Ke Za Zhi. 2006 May;44(5):324-8.
5
Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.延迟静脉注射免疫球蛋白治疗增加了不同状态川崎病患儿冠状动脉病变的风险。
Postgrad Med. 2018 May;130(4):442-447. doi: 10.1080/00325481.2018.1468712. Epub 2018 May 10.
6
Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.静脉注射丙种球蛋白在川崎病冠状动脉病变防治中疗效的再评估
J Huazhong Univ Sci Technolog Med Sci. 2005;25(3):348-50, 370. doi: 10.1007/BF02828164.
7
[Risk factors for coronary artery lesions in children with Kawasaki disease].[川崎病患儿冠状动脉病变的危险因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2012 Dec;14(12):938-41.
8
[Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].静脉注射免疫球蛋白1g/kg和2g/kg对川崎病的治疗效果:一项比较与随访研究
Zhonghua Er Ke Za Zhi. 2006 Dec;44(12):891-5.
9
[The mediation mechanism of coronary artery lesions in both male and female patients with Kawasaki disease].[川崎病男性和女性患者冠状动脉病变的中介机制]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Dec 10;40(12):1634-1638. doi: 10.3760/cma.j.issn.0254-6450.2019.12.024.
10
[Risk factors for coronary artery lesions secondary to Kawasaki disease in children].[儿童川崎病继发冠状动脉病变的危险因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2015 Sep;17(9):927-31.

引用本文的文献

1
Neutropenia Is Not Associated With the Outcomes in Patients With Kawasaki Disease.中性粒细胞减少与川崎病患者的预后无关。
Front Pediatr. 2021 Jun 4;9:652346. doi: 10.3389/fped.2021.652346. eCollection 2021.

本文引用的文献

1
Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease - A Multicenter Retrospective Study.血清腱生蛋白-C作为川崎病冠状动脉病变风险和静脉注射免疫球蛋白抵抗性的新型预测指标——一项多中心回顾性研究
Circ J. 2016 Oct 25;80(11):2376-2381. doi: 10.1253/circj.CJ-16-0563. Epub 2016 Oct 15.
2
Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.循环血小板-中性粒细胞聚集体在川崎病中起重要作用。
Circ J. 2015;79(6):1349-56. doi: 10.1253/circj.CJ-14-1323. Epub 2015 Mar 19.
3
Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).
急性川崎病的医学治疗指南:日本小儿心脏病学会和心脏外科学会研究委员会报告(2012年修订版)
Pediatr Int. 2014 Apr;56(2):135-58. doi: 10.1111/ped.12317.
4
Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.中国川崎病的临床特征及冠状动脉病变的危险因素。
Pediatr Infect Dis J. 2013 Oct;32(10):e397-402. doi: 10.1097/INF.0b013e31829dd45e.
5
Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.脑钠肽对川崎病冠状动脉病变风险的预测
Pediatr Cardiol. 2011 Dec;32(8):1106-9. doi: 10.1007/s00246-011-9986-8. Epub 2011 Apr 13.
6
Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.非冠状动脉心脏异常与川崎病急性期冠状动脉扩张和实验室炎症标志物有关。
J Am Coll Cardiol. 2011 Jan 4;57(1):86-92. doi: 10.1016/j.jacc.2010.08.619.
7
[Effect of intravenous immunoglobulin on neutrophil counts in children with Kawasaki disease].
Zhongguo Dang Dai Er Ke Za Zhi. 2010 Dec;12(12):991-2.
8
Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.川崎病相关冠状动脉异常的危险因素因年龄而异。
Eur J Pediatr. 2009 Nov;168(11):1315-21. doi: 10.1007/s00431-009-0925-0. Epub 2009 Jan 22.
9
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病的诊断、治疗及长期管理:美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎及川崎病委员会为卫生专业人员发布的声明
Pediatrics. 2004 Dec;114(6):1708-33. doi: 10.1542/peds.2004-2182.
10
Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease.利用实验室数据识别川崎病所致巨大冠状动脉瘤的危险因素。
Pediatr Int. 2004 Feb;46(1):33-8. doi: 10.1111/j.1442-200X.2004.01840.x.